RecallReported September 2, 2026

Class I recall by Fresenius Kabi USA, LLC

Tyenne (tocilizumab-aazg) Injection, 400 mg/20 mL (20 mg/mL), 20 mL vial, Rx Only, Manufactured by Fresenius Kabi USA, LLC, Lake Zurich, Ill…

FDA's record ↗

FDA's enforcement report of September 2, 2026 lists a Class I recall by Fresenius Kabi USA, LLC of Lake Zurich, IL. Product: Tyenne (tocilizumab-aazg) Injection, 400 mg/20 mL (20 mg/mL), 20 mL vial, Rx Only, Manufactured by Fresenius Kabi USA, LLC, Lake Zurich, Ill…. Status: Ongoing.

On the record

Recalling firm
Fresenius Kabi USA, LLC
Location
Lake Zurich, IL
Classification
Class I
Status
Ongoing
Recall number
D-0827-2026
Product type
Drugs
Brand names
TYENNE
Generic names
TOCILIZUMAB-AAZG
Recall initiated
2026-08-10
Reported by FDA
2026-09-02
Source
FDA enforcement reports ↗

The full record

An account shows the reason for the recall, where the product was distributed and the lots.

What a recall is

FDA classifies a recall by the hazard. Class I: a reasonable probability that the product will cause serious adverse health consequences or death. Class II: the product may cause temporary or medically reversible harm, or the probability of serious harm is remote. Class III: the product is not likely to cause adverse health consequences.

More

Watch Fresenius Kabi USA, LLC

A free account shows the last 7 days of every record. Pro adds a watchlist: one email when FDA acts on a company you name.

From FDA enforcement reports. The record may have changed since it was read.

Approve Suite is not affiliated with FDA, or with Fresenius Kabi USA, LLC.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.